Brensocatib, developed by Insmed Inc., is anticipated to revolutionize respiratory care for bronchiectasis patients. The drug has received FDA Priority Review, with a potential market launch in the third quarter…
Evaxion Biotech raised $10.8 million through a recent public offering of nearly 4 million ADSs. The offering includes warrants for investors to buy up to 50% more ADSs at $2.71…
**Innovation Takes a Leap Forward** Angelos Stergiou, CEO of SELLAS Life Sciences, has revealed that his team is on the verge of completing a groundbreaking leukemia vaccine. But that's just…
Dimension Ventures is making headlines as it embarks on an ambitious journey, setting out to raise $500 million for its second fund in under two years. This initiative is focused…
In the competitive realm of biotechnology, **BridgeBio Pharma, Inc.** has emerged victorious with a significant regulatory approval. The company successfully secured FDA approval for its groundbreaking cardiovascular medication, acoramidis, known…
**Sana Biotechnology's Bold December Move: What You Need to Know** Sana Biotechnology, Inc. (NASDAQ: SANA) is set to unveil some exciting updates. The company, renowned for its pioneering work on…